Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial ; volume:23 ; number:1 ; day:11 ; month:12 ; year:2023 ; pages:1-12 ; date:12.2023
BMC pulmonary medicine ; 23, Heft 1 (11.12.2023), 1-12, 12.2023
- Urheber
-
Blum, Claudine A.
Roethlisberger, Eva A.
Cesana-Nigro, Nicole
Winzeler, Bettina
Rodondi, Nicolas
Blum, Manuel R.
Briel, Matthias
Mueller, Beat
Christ-Crain, Mirjam
Schuetz, Philipp
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-023-02794-w
- URN
-
urn:nbn:de:101:1-2024022614535136222826
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blum, Claudine A.
- Roethlisberger, Eva A.
- Cesana-Nigro, Nicole
- Winzeler, Bettina
- Rodondi, Nicolas
- Blum, Manuel R.
- Briel, Matthias
- Mueller, Beat
- Christ-Crain, Mirjam
- Schuetz, Philipp
- SpringerLink (Online service)
Ähnliche Objekte (12)
Childhood community-acquired pneumonia
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study
The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia
Childhood community-acquired pneumonia
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study
The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia
Childhood community-acquired pneumonia
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study